WJA  Vol.4 No.3 , September 2014
Utility of C-Reactive Protein and Procalcitonin for Detecting Bloodstream Infection in Patients with HIV/AIDS
Abstract: Human immunodeficiency virus (HIV) infected persons, are at high risk for developing a bloodstream infection. In order to evaluate the usefulness of C-reactive protein (CRP) and procalcitonin (PTC) in the detection of bloodstream infection in HIV, a case-control study was conducted from February to December 2012. PCT and CPR levels were measured in 2 groups. PCT concentrations were measured by the VIDAS® Brahms PCT assay, and CRP concentrations were determined by CRP latex. Values were calculated for both biomarkers and discriminative ability of PCT and CRP was analyzed using ROC curves. There were no significant differences between the study group and the control groups with respect to CRP levels. However, they were much higher PCT levels in patients with bacteremia. PCT showed greater discriminating ability compared to CRP, and proved to be a valuable tool for the detection of systemic bacterial infections in HIV infected patients.
Cite this paper: Marshall, A. , Castellanos, T. , Motas, I. , Rodriguez, D. , Romaní, M. and Ávila, J. (2014) Utility of C-Reactive Protein and Procalcitonin for Detecting Bloodstream Infection in Patients with HIV/AIDS. World Journal of AIDS, 4, 287-292. doi: 10.4236/wja.2014.43033.

[1]   Yehia, B., Fleishman, J., Wilson, L., Hicks, P., Gborkorquellie, T. and Gebo, K. (2011) Incidence of and Risk Factors for Bacteraemia in HIV-Infected Adults in the Era of Highly Active Antiretroviral Therapy. HIV Medicine, 12, 535-543.

[2]   Loza, E., Planes, A. and Rodriguez, M. (2003) 3a. Hemocultivos 2003. In: Cercenado, E. and Canton, R., Eds., Clinical Microbiology Procedures, Recommendations of the Spanish Society of Clinical Microbiology and Infectious Diseases.

[3]   Simon, L., Gauvin, F., Amre, D., Saint-Louis, P. and Lacroix, J. (2004) Serum Procalcitonin and C-Reactive Protein Levels as Markers of Bacterial Infection: A Systematic Review and Meta-Analysis. Clinical Infectious Diseases, 39, 206-217.

[4]   Joo, K., Park, W., Lim, M.-J., Kwon, S.-R. and Yoon, J. (2011) Serum Procalcitonin for Differentiating Bacterial Infection from Disease Flares in Patients with Autoimmune Diseases. Journal of Korean Medical Science, 26, 1147-1151.

[5]   Póvoa, P., Coelho, L., Almeida, E., Fernández, A., Mealha, R., Moreira, P., et al. (2006) Early Identification of Intensive Care Unit-Acquired Infections with Daily Monitoring of C-Reactive Protein: A Prospective Observational Study. Critical Care, 10, R63.

[6]   Gilbert, D. (2010) Use of Plasma Procalcitonin Levels as an Adjunct to Clinical Microbiology. Journal of Clinical Microbiology, 48, 2325-2329.

[7]   Diaz, R., Oujo, E., Guevara, P., Guillen Campuzano, E., Soria Marin, J.L., Munoz Pérez, M., et al. (2011) Procalcitonin: Utility and Recommendations for Laboratory Measurement. SEQC Documents.

[8]   Limper, M., de Kruif, M., Ajubi, N., van Zanten, A., Brandjes, D., et al. (2011) Procalcitonin as a Potent Marker of Bacterial Infection in Afro-Caribbean Febrile Patients at the Emergency Department. European Journal of Clinical Microbiology & Infectious Diseases, 30, 831-836.

[9]   Whicher, J., Bienvenu, J. and Monneret, G. (2001) Procalcitonin as an Acute Phase Marker. Annals of Clinical Biochemistry, 38, 483-493.

[10]   Jeong, S., Park, Y., Cho, Y. and Kim, H.S. (2012) Diagnostic Utility of Procalcitonin and C-Reactive Protein for the Prediction of Bacteremia Determined to by Blood Culture. Clinica Chimica Acta, 413, 1731-1736.

[11]   Prat, C. and Dominguez, J. (2004) Procalcitonin and Markers of Infection. Educación continuada en el laboratorio clínico, 7, 38-43.

[12]   Aznar-Oroval, E., Sánchez-Yepes, M., Lorente-Alegre, P., San Juan-Gadea, M.C., Ortiz-Mu?oz, B., Pérez-Ballestero, P., Picón-Roig, I. and Maíquez-Richart, J. (2010) Diagnostic Value of Procalcitonin, Interleukin 8, Interleukin 6, and C-Reactive Protein for Detecting Bacteremia and Fungemia in Cancer Patients. Enfermedades Infecciosas Y Microbiologia Clinica, 28, 273-277.

[13]   Tromp, M., Lansdorp, B., Bleeker, C., Klein, J., Kullberg, B. and Pickkers, P. (2012) Serial and Panel Analyzes of Biomarkers Do Not Improve the Prediction of Bacteremia Compared to One Procalcitonin Measurement. Journal of Infection, 65, 292-301.

[14]   Kim, M.H., Lim, G., Kang, S.Y., Lee, W.I., Suh, J.T. and Lee, H.J. (2011) Utility of Procalcitonin as an Early Diagnostic Marker of Bacteremia in Patients with Acute Fever. Yonsei Medical Journal, 52, 276-281.

[15]   Harbarth, S., Holeckova, K., Froidevaux, C., Pittet, D., Ricou, B., Grau, G., et al. (2001) Geneva Sepsis Network Diagnostic Value of Procalcitonin, Interleukin-6, and Interleukin-8 in Critically Ill Patients with Suspected Sepsis Admitted. American Journal of Respiratory and Critical Care Medicine, 164, 396-402.

[16]   Christ-Crain, M., Jaccard-Stolz, D., Bingisser, R., Gencay, M.H., Huber, P.R., Tamm, M., et al. (2004) Effect of Procalcitonin-Guided Treatment on Antibiotic Use and Outcome in Lower Respiratory Tract Infections: Cluster Randomized, Single-Blinded Intervention Trial. The Lancet, 363, 600-607.

[17]   Mauro, M., Cavalcantia, P., Peruginia, D., Notob, A., Sperlìc, D. and Giraldia, C. (2012) Diagnostic Utility of Light-Cycler Assays SeptiFast and Procalcitonin in the Diagnosis of Bloodstream Infection in Immunocompromised Patients. Diagnostic Microbiology and Infectious Disease, 73, 308-311.

[18]   Koivula, I., Hamalainen, S., Jantunen, E., Pulkki, K., Kuittinen, T., Nousiainen, T., et al. (2011) Elevated Procalcitonin Predicts Gram-Negative Sepsis in Haematological Patients with Febrile Neutropenia. Scandinavian Journal of Infectious Diseases, 43, 471-478.

[19]   Kim, D.Y., Lee, Y.S., Ahn, S., Chun, Y.H. and Lim, K.S. (2011) The Usefulness of Procalcitonin and C-Reactive Protein as Early Diagnostic Markers of Bacteremia in Cancer Patients with Febrile Neutropenia. Cancer Research and Treatment, 43, 176-180.

[20]   Tsangaris, I., Plachouras, D., Kavatha, D., Gourgoulis, G.M., Tsantes, A., Kopterides, P., et al. (2009) Diagnostic and Prognostic Value of Procalcitonin among Febrile Critically Ill Patients with Prolonged ICU Stay. BMC Infectious Diseases, 9, 213-222.

[21]   Riedel, S., Bourbeau, P., Swartz, B., Brecher, S., Carroll, K.C., Stamper, P.D., et al. (2008) Timing of Specimen Collection for Blood Cultures from Febrile Patients with Bacteremia. Journal of Clinical Microbiology, 46, 1381-1385.

[22]   Charles, P., Ladoire, S., Snauwaert, A., Prin, S., Aho, S., Pechinot, A., et al. (2008) Impact of Previous Sepsis on the Accuracy of Procalcitonin for the Early Diagnosis of Blood Stream Infection in Critically Ill Patients. BMC Infectious Diseases, 8, 163.

[23]   Suberviola, B., Castellanos Ortega, A., González Castro, A., Garcia Astudillo, L.A. and Fernández Miret, B. (2011) Prognostic Value of Procalcitonin Clearance, C-Reactive Protein and Leukocytes in Septic Shock. Medicina Intensiva, 36, 177-184.

[24]   Cerda, J. and Cifuentes, L. (2012) Using ROC Curves in Clinical Research. Theoretical and Practical Aspects. Revista Chilena de Infectología, 29, 138-114.

[25]   Bele, N., Darmon, M., Coquet, I., Feugeas, J.P., Legriel, S., Adaoui, N., et al. (2011) Diagnostic Accuracy of Procalcitonin in Critically Ill Immunocompromised Patients. BMC Infectious Diseases, 11, 224.

[26]   Massaro, K.S., Costa, S.F., Leone, C. and Chamone, D. (2007) Procalcitonin (PCT) and C-Reactive Protein (CRP) as Severe Systemic Infection Markers in Febrile Neutropenic Adults. BMC Infectious Diseases, 7, 137.